drugset / Trial / NCT06925581
A Trial of HRS-6768 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The study is being conducted to evaluate the pharmacokinetics, radiation dosimetry, safety and preliminary efficacy of HRS-6768. To explore the reasonable dosage of HRS-6768 in the treatment of patients with advanced solid tumors.
Timeline
- Start
- 2025-04-24
- Primary completion
- 2026-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-6768 | Unknown | — | — |